Oxidant/antioxidant status in premenstrual syndrome

[1]  R. Soulimani,et al.  Evidence that oxidative stress is linked to anxiety-related behaviour in mice , 2008, Brain, Behavior, and Immunity.

[2]  M. De la Fuente,et al.  Impairment of several immune functions in anxious women. , 2007, Journal of psychosomatic research.

[3]  M. Çekmen,et al.  Malon dialdehyde, nitrite and adrenomedullin levels in patients with premenstrual syndrome , 2007, Archives of Gynecology and Obstetrics.

[4]  David L. Roberts,et al.  Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. , 2006, Journal of women's health.

[5]  M. Runge,et al.  Differential Activation of Mitogenic Signaling Pathways in Aortic Smooth Muscle Cells Deficient in Superoxide Dismutase Isoforms , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[6]  O. Erel,et al.  Measurement of the total antioxidant response in preeclampsia with a novel automated method. , 2005, European journal of obstetrics, gynecology, and reproductive biology.

[7]  M. Runge,et al.  Oxidative Stress and Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[8]  M. Evans,et al.  Oxidative DNA damage and disease: induction, repair and significance. , 2004, Mutation research.

[9]  M. Harma,et al.  Comparison of protein carbonyl and total plasma thiol concentrations in patients with complete hydatidiform mole with those in healthy pregnant women , 2004, Acta obstetricia et gynecologica Scandinavica.

[10]  U. Halbreich,et al.  The diagnosis of premenstrual syndromes and premenstrual dysphoric disorder - clinical procedures and research perspectives , 2004, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[11]  S. Khanzode,et al.  Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors , 2003, Redox report : communications in free radical research.

[12]  V. Birzniece,et al.  Pathogenesis in Menstrual Cycle‐Linked CNS Disorders , 2003, Annals of the New York Academy of Sciences.

[13]  D. Rubinow,et al.  Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome , 2003, Biological Psychiatry.

[14]  U. Halbreich.  The etiology, biology, and evolving pathology of premenstrual syndromes , 2003, Psychoneuroendocrinology.

[15]  E. Freeman.  Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis 1 1 Adapted from the symposium on Premenstrual Syndrome and Premenstrual Dysphoric Disorders, July 17, 2000, Rhodes, Greece , 2003, Psychoneuroendocrinology.

[16]  L. Kahn,et al.  The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) , 2003, Psychoneuroendocrinology.

[17]  B. Kinon,et al.  Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone 1 1 This work was sponsored by Eli Lilly and Company. , 2003, Psychoneuroendocrinology.

[18]  R. Rola,et al.  [The antioxidant-prooxidant balance in pregnancy complicated by spontaneous abortion]. , 2001, Ginekologia polska.

[19]  A. Rao,et al.  Antioxidant status and lipid peroxidation in premenstrual syndrome: a preliminary study. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[20]  N. Turhan,et al.  Intermittent versus continuous sertraline therapy in the treatment of premenstrual dysphoric disorders. , 2001, International journal of fertility and women's medicine.

[21]  David Silbersweig,et al.  SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder , 2000, Biological Psychiatry.

[22]  J. Strain,et al.  Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. , 1999, Methods in enzymology.

[23]  K. Kendler,et al.  Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. , 1998, The American journal of psychiatry.

[24]  M. Steiner,et al.  Premenstrual syndromes. , 1997, Clinical obstetrics and gynecology.

[25]  J. Nourooz-Zadeh,et al.  Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. , 1994, Analytical biochemistry.

[26]  J. Marshall,et al.  Pulsatile LH secretion in women with premenstrual syndrome (PMS): Evidence for normal neuroregulation of the menstrual cycle , 1992, Psychoneuroendocrinology.

[27]  K. Rickels,et al.  Ineffectiveness of progesterone suppository treatment for premenstrual syndrome , 1991, JAMA.

[28]  K. Rickels,et al.  Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. , 1990 .

[29]  J. Endicott,et al.  Premenstrual changes and changes in gonadal hormones , 1986, Acta psychiatrica Scandinavica.

[30]  Raymond Greene,et al.  The Premenstrual Syndrome , 1953, British Journal of Psychiatry.

[31]  J. Bancroft,et al.  Mood, Sexuality, Hormones, and the Menstrual Cycle. II. Hormone Levels and Their Relationship to the Premenstrual Syndrome , 1983, Psychosomatic medicine.

[32]  大川 博,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction , 1979 .

[33]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.